Sandoz is a global leader in generic and biosimilar medicines, spun off from Novartis in 2023 as a standalone company. It manufactures and markets generic pharmaceuticals and biosimilars but operates as a branded pharmaceutical company, not a contract manufacturer for third parties.
generic pharmaceuticals, biosimilar medicines, sterile injectables, branded generics
6 sites worldwide
No reviews available yet.
No documents available.